In view of significance of a strong IPR regime, the Department Related Parliamentary Standing Committee on Commerce, in this Report, has observed and analysed the overall scenario of IPR regime in India and its contribution in promoting innovation and entrepreneurship in the country.

Order of the High Court of Delhi in the matter of Dharmendra Kumar Aggarwal Vs Govt of NCT of Delhi dated 10/05/2021. The present petition is concerned with the supply and availability of the drug Tocilizumab 400 MG for COVID-19 patients who are prescribed the same. The counsel appearing for Roche India informed the court that considering the recent spike of the COVID-19 pandemic, Roche India has, on its  own, decided to immediately supply 10,000 doses of Tocilizumab 400 MG free of cost.

This report examines the landscape of low-carbon energy technologies and covers the past, present and future of clean energy innovation. Recent developments provide welcome grounds for optimism.

The Ministry of Law and Justice has notified the Tribunal Reforms (Rationalisation and Conditions of Service), Ordinance 2021 to reduce Tenure of Tribunal Members, their appointment.

On February 09, 2021, the Government of India vide the Ministry of Commerce and Industry published the draft Patents (Amendment) Rules, 2021 (hereinafter referred to as the “new draft Rules”) as a proposal to further amend the Patents Rules, 2003.

Growth in the region is expected to slow sharply to 2.2% in 2020 under the effects of the current health emergency and then rebound to 6.2% in 2021.

Order of the High Court of Delhi in the matter of Pioneer Overseas Corporation Vs Chairperson, Protection of Plant Varieties and Farmers Rights & Others dated 01/07/2019 regarding registration of a variety of maize under the Protection of Plant Varieties and Farmers’ Rights Act, 2001.

India has consistently been climbing up its Global Innovation Index (GII) rankings since 2015, but the country still has to improve on many indicators to catch up with China and others in the list of 126 nations.

Despite India’s enormous technological potential, indigenous medicinal knowledge and various initiatives by the government and industry at translational cycle, the country carries a global disease burden of 21%, majorly contributed by dual disease burden. Public health faces the major anomalies of 3A (accessibility, affordability, availability) of the healthcare sector, possibly due to restrictive coordination among stakeholders, transiting disease profile, undeveloped delivery system and regulatory mechanisms.

Order of the High Court of Delhi in the matter of Nuziveedu Seeds Ltd. And Others Vs Monsanto Technology LLC And Others dated 11/04/2018 regarding Monsanto's appeal for patents on its BT cotton seeds in India. Monsanto claims that the patent is a biotech invention containing the infusion of Bt gene into the cotton genome. The Bt. bacterium eradicates pests afflicting the cotton plant. Monsanto states that the patent does not cover plants per se, but does cover components that can be termed microbiological processes and microorganisms, thus patentable under the Patents Act.

Pages